Sign in

CIK 0001699350

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

SHOULDER INNOVATIONS, INC.

Sign in to watch
Ticker
SI
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
270538764
Phone
+1 616-294-1026
Business address
1535 STEELE AVENUE SW, SUITE B, GRAND RAPIDS, MI, 49507
  1. 4 Option exercise Chief Operating Officer acquired 21,664 shares (option exercise)
  2. 4 Open-market buy Chief Financial Officer bought 2,000 shares at $15.00 ($30,000)
  3. 4 Shares withheld for taxes Director gave up 7,006 shares (to pay taxes)
  4. 4 Open-market buy Director bought 1,000 shares at $14.84 ($14,840)
  5. 4 Open-market buy CEO & Executive Chairman bought 2,200 shares at $15.18 ($33,392)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Option exercise CEO & Executive Chairman acquired 12,062 shares (option exercise)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Grant or award Chief Financial Officer acquired 1,076 shares (grant or award)
  13. 4 Grant or award See Remarks acquired 1,041 shares (grant or award)
  14. 4 Grant or award CEO & Executive Chairman acquired 1,661 shares (grant or award)
  15. 4 Grant or award Chief Operating Officer acquired 477 shares (grant or award)
  16. 4 Open-market buy Chief Financial Officer bought 2,000 shares at an average $14.82 ($29,632)
  17. 4 Open-market buy CEO & Executive Chairman bought 7,200 shares at an average $14.86 ($107,009)
  18. 4 Open-market buy CHIEF FINANCIAL OFFICER bought 1,600 shares at $15.67 ($25,072)
  19. 4 Option exercise SEE REMARKS acquired 94,394 shares (option exercise)
  20. 4 Open-market buy CEO & EXECUTIVE CHAIRMAN bought 8,000 shares at an average $15.34 ($122,755)

Page 2 of 4 · 65 filings